跳至主要内容
临床试验/NCT00849992
NCT00849992已完成4 期

Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis

Norwegian University of Science and Technology1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
53
试验地点
1
主要终点
clinical and pathological complete cure rates.

研究概览

简要总结

Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.

详细描述

Randomized study comparing imiquimod 5% with photodynamic therapy for actinic cheilitis. Histological, efficacy, epidemiological and clinical data will be collected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical findings of actinic cheilitis.
  • Histological findings demonstrating epithelial changes equal to or greater than mild epithelial dysplasia in severity (mild - moderate - severe).
  • Age above
  • Willingness to take post-treatment biopsy.

排除标准

  • Disorders predisposing to photosensitivity (porphyria, SLE).
  • Pregnancy or nursing.
  • Known allergy to any excipients in the study creams.
  • prescribed topical retinoids, 5-fluorouracil, cryodestruction, surgical excision and curettage.

研究组 & 干预措施

Imiquimod 5%

Other

Patients randomized to this arm will receive treatment with imiquimod 5%

干预措施: Imiquimod 5% (Drug)

Photodynamic therapy

Other

Patients will be randomized to receive photodynamic therapy twice at a 2 week interval to the affected area.

干预措施: Photodynamic therapy (Procedure)

结局指标

主要结局

clinical and pathological complete cure rates.

时间窗: 3 and 12 months after therapy

次要结局

  • clinical, safety, epidemiological and histopathological data(post-treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验